Shire (SHPGY) Grabs U.S. Rights to Resolor
Shire plc (Nasdaq: SHPGY), has acquired the rights to develop and market Resolor (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V. Terms of the agreement have not been disclosed.
Resolor, a prokinetic, is part of Shire's gastrointestinal (GI) portfolio in Europe and is approved for use in 33 countries for the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. Resolor is currently available in Germany, Ireland, Belgium, France, Greece and the United Kingdom, and will be commercially available in Italy in mid-January 2012. Additional launches throughout Europe are planned for 2012.
Under the terms of the agreement, the US rights to the Resolor trademark will be transferred to Shire.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Resolor, a prokinetic, is part of Shire's gastrointestinal (GI) portfolio in Europe and is approved for use in 33 countries for the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. Resolor is currently available in Germany, Ireland, Belgium, France, Greece and the United Kingdom, and will be commercially available in Italy in mid-January 2012. Additional launches throughout Europe are planned for 2012.
Under the terms of the agreement, the US rights to the Resolor trademark will be transferred to Shire.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Goldman Sachs Says Buy Shire plc (SHPGY) On Recent Weakness, Keeps Top Rating
- CVR Energy (CVI) Hires Jefferies for Sale Process
- Wesco Aircraft (WAIR) to Acquire Interfast in C$134M Deal
Create E-mail Alert Related Categories
FDA, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
